Table 4.
Study characteristics of bone scintigraphy for detection of periprosthetic knee infection
Study | Tracer | Doses | Criteria for infection |
---|---|---|---|
Palestro et al. [34] | 99mTc-MDP | 740 MBq | When hyperperfusion and hyperemia around at least one component of the prosthesis were present on dynamic and blood pool images and periprosthetic activity of at least Grade 2 around the same component was present on delayed images |
Nijhof et al. [27] | 99mTc-MDP | 600 MBq | When there was increased activity in at least two phases (blood pool and late phase) in the area of interest |
van Acker et al. [50] | 99mTc-MDP | 740 MBq | Any periprosthetic focal uptake in the delayed phase |
Larikka et al. [20] | 99mTc-HDP | 550 MBq | Uptake in the arterial/flow phase |
Rubello et al. [40] | 99mTc-MDP | NR | Uptake in the arterial/flow phase |
Granados et al. [12] | 99mTc-HDP | 925 MBq | Uptake in the arterial/flow phase |
Diagnostic odds ratio 8.956; heterogeneity chi-square = 8,09 (df = 5) p = 0.151; Inconsistency (I2) = 38,2%; 99 mTc = 99m-technetium; MDP = methylenediphosphonate; HDP = hydroxymethylenediphosphonate.